Geriatric Pharmacoepidemiology

(B-154) A Qualitative Study on Iatrogenesis: Perspectives from Healthcare Professionals

(B-157) Aetiology, Prevalence and Pharmacological Management of Rheumatoid Arthritis among geriatrics at Kenyatta National Hospital (2018-2022)

(B-152) AI-Assisted Medication Management: Reducing Risks and Costs in Hyper-Polypharmacy Patients

(SLA-167) Antibiotic use and risk of inflammatory bowel disease in older adults: a nationwide self-controlled case series study

(A-160) Antidepressant Use Among US Nursing Home Residents with ADRD in 2018

(B-142) Antithrombotic Treatment after Left Atrial Appendage Occlusion in Older Atrial Fibrillation Patients

(A-147) Cardiovascular, Kidney, and Safety Outcomes following GLP-1 Receptor Agonist initiation in Adults with Alzheimer's Disease and Related Dementias: A Target Trial Emulation Study

(B-158) Central Nervous System (CNS) medication use patterns before suicide among older adults

(A-149) Comparing cancer screening prevalence among older adults in Medicare Advantage encounter data and Fee-For-Service claims

(B-149) Constructing a frailty index (FI) using the Behavioral Risk Factor Surveillance System: Application in lung cancer screening

(A-152) Costs and Lost Time for Employees whose Spouses have Dementia and/or Alzheimer’s Disease and Patient Direct Costs

(B-150) Determinants Associated with Use of Angiotensin II Inhibiting vs Angiotensin II Stimulation Antihypertensive Medications among Medicare Beneficiaries

(A-146) Development of Model for Predicting Early Mortality in Older Cancer Patients Treated with Chemotherapy

(B-151) Difference in Awareness of Osteoporosis and Bone Mineral Density Testing between Older Men and Women

(A-148) Differences in the prevalence of diagnosis code groups for comorbidities using Medicare Advantage encounter data and Fee-For-Service claims

(B-143) Discontinuation Pattern of Disease-modifying Therapies among Older Adults with Multiple Sclerosis

(B-155) Disparities in Nonpharmacologic Chronic Pain Treatments for Older Adults with Alzheimer’s disease and Related Dementias

(B-146) Double Burden: Anticholinergic and Sedative Medication Impact on Older Adults' Health Outcomes

(A-155) Effect of statin discontinuation on mortality among older adults with and without cardiovascular disease

(SLA-166) Effectiveness, Safety, and Costs of Initiating Gabapentin Versus Pregabalin among Older Adults with Chronic Opioid Use

(A-161) Hospital admissions due to adverse drug reactions and adverse drug events in older adults: A systematic review

(B-147) Impact analysis of the recent policy interventions for regional polypharmacy reduction in Japan with high older population: A nationwide serial cross-sectional study (April 2020-March 2023)

(B-153) Improving Quality-of-Care and Preventing Iatrogenesis for a Healthy Ageing – A Survey on Portuguese Healthcare Professionals

(B-141) Increased Incidence of Parkinson's Disease Associated with Antiseizure Medication Use

(SLA-160) Magnitude and Patterns of Potential Diuretic Prescribing Cascades after Calcium Channel Blocker Initiation in Medicare Beneficiaries with and without Congestive Heart Failure

(SLA-164) Mortality in Patients With Parkinson’s Disease Psychosis Using Pimavanserin Versus Other Antipsychotics

(B-156) Motor Vehicle Crash Risk in Older Adults with Alzheimer’s Disease After Acetylcholinesterase Inhibitor Initiation: A Sequential Target Trial Emulation

(SLA-163) Multidomain frailty index from routine health data and medication use in older patients with and without dementia in Australian hospitals

(A-158) Patterns of Long-Term Bisphosphonate Use and Drug Holiday Among U.S. Medicare Beneficiaries

(A-154) Predicting Response to Mono and Dual Antidementia Pharmacotherapy Among Nursing Home Residents

(A-156) Prescription and Non-Prescription Medication Use Before and After a Herpes Zoster Diagnosis Among Nursing Home Residents in the United States

(SLA-161) Prevalence and Mortality of HIV-Associated Neurocognitive Disorder (HAND) in Older Medicare Beneficiaries

(A-162) Prospective Validation of the Adverse Drug Reactions in an Ageing Population Risk Prediction (ADAPTiP) tool and Comparison with Previously Described Risk Prediction Tools: Study Protocol

(A-157) Psychotropic medication prescribing among older adults before and after dementia diagnosis: a retrospective study in Yinzhou, China

(A-159) Relationship between sociodemographic factors and discontinuation of high-risk long-term medication in US older adults

(B-148) REpositioning of Medications IN Dementia (REMIND): Evaluating fitness for purpose of the SNDS French nationwide claims database

(SLA-165) Risk of Incident Atrial Fibrillation among Female Users of Osteoporosis Treatments

(A-153) The association between metformin-based regimens and cognitive performance in participants with type2 diabetes in the UK Biobank

(A-145) The comparative risk of diagnosed depression among older men with metastatic castration resistant prostate cancer initiating enzalutamide versus abiraterone

(SLA-162) The Prevalence of Central Nervous System-Active Polypharmacy in U.S. Nursing Homes During the COVID-19 Visitation Restriction

(B-145) Timing of Symptomatic Treatment Discontinuation on Neuropsychiatric and Functional Outcomes in Alzheimer's Disease and Related Dementias

(B-144) Trends in Drug-Drug Interactions Among US Older Adults, 2015-2016 vs. 2021-2023